Dr. Mir Shahnawaz’s Landmark Study on Abrocitinib in Atopic Dermatitis Published in International Medical Journal
In a significant milestone for Indian dermatological research, a first-of-its-kind comparative clinical study involving the use of Abrocitinib in the treatment of moderate to severe Atopic Dermatitis has been published in the CUREUS Journal, a PubMed-indexed international medical journal under Springer. The study, authored by Dr. Mir Shahnawaz, a renowned Kashmiri dermatologist and the Founder…